If physicians and other healthcare workers are not exempted from the $100,000 fee, the rheumatology workforce may be negatively affected, possibly increasing pressure on existing providers and extending patient wait times.
Articles by From the College
Rheumatology Research Foundation Launches $1 Million Emergency Fund to Safeguard Innovation
In the wake of unprecedented federal research cuts, the new $1 million emergency funding commitment aims to protect vital projects and the future of patient care.
Advocacy Opportunities Abound at ACR Convergence
At ACR Convergence 2025, the ACR advocacy team will be hosting a slate of programming to help you understand the power of advocacy and prepare you to add your voice in support of the rheumatology community.
ACR Leads Sign-on Letter to Cigna Opposing Downcoding of E/M Claims
The ACR recently led a rheumatology community letter to Cigna opposing the payer’s decision to downcode level 4 and 5 evaluation and management claims.
Coming Soon: Rheumatology Physician & Faculty Survey
Two upcoming surveys of ACR members will help identify trends and issues affecting academic and private practice rheumatology, as well as provide benchmarking data and inform advocacy efforts.
Urge Congress to Avoid Disruption to Telemedicine
Telehealth is at risk. Congress must act before the end of September to maintain vital flexibility and reimbursement for telemedicine services.
ACR’s Response to Proposed Physician Medicare Cuts Garners National Media Attention
ACR President Carol Langford, MD, MHS, is making headlines as a leading voice in the fight against proposed Medicare reimbursement cuts that threaten the sustainability of rheumatology practices and patient access to care.
Share Your Story: Help Shape the Future of Noncompete Agreements for Rheumatologists
The Federal Trade Commission is seeking input about the use and impacts of noncompete agreements, with particular interest in the healthcare sector. ACR/ARP members are encouraged to share your experiences about how such agreements have affected your career and patients.
AHIP Confirms Continued Coverage of ACIP-Recommended Vaccines Through End of 2026
All vaccines recommended by the CDC’s ACIP as of Sept. 1, 2025—including updated COVID-19 and influenza shots—will be covered by health plans with no cost sharing for patients through the end of 2026.
2024 Traditional MIPS & MVP Final Scores Now Available
MIPS-eligible clinicians should review their scores to confirm performance. Any scoring concerns can be addressed through a targeted review